Imugene Ltd (IMU)

Sydney
0.285
-0.020(-6.56%)
  • Volume:
    66,006,653
  • Bid/Ask:
    0.280/0.285
  • Day's Range:
    0.275 - 0.315

IMU Overview

Prev. Close
0.305
Day's Range
0.275-0.315
Revenue
-
Open
0.31
52 wk Range
0.092-0.625
EPS
0
Volume
66,006,653
Market Cap
1.65B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
26,135,623
P/E Ratio
-
Beta
2.73
1-Year Change
159.09%
Shares Outstanding
5,805,705,833
Next Earnings Date
22 Feb 2022
What is your sentiment on Imugene Ltd?
or
Market is currently closed. Voting is open during market hours.

Imugene Ltd Company Profile

Employees
5
Market
Australia

Imugene Limited is an Australia-based clinical-stage immuno-oncology company. The Company is engaged in developing immunotherapies that seeks to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness the body’s immune system against cancerous tumors. Its product pipeline includes multiple immunotherapy B-cell vaccine candidates and an oncolytic virotherapy (CF33) aimed at treating a variety of cancers in combination with care drugs and immunotherapies such as chimeric antigen receptor T cells (CAR T’s) for solid tumors. Its PD-1 B-cell immunotherapy, known as PD1-Vaxx, aims to induce the body to produce polyclonal antibodies that block PD-1 signaling, and thus produce an anticancer effect similar to Keytruda, Opdivo and the other immune checkpoint inhibitor monoclonal antibodies for the treatment of cancers. Its clinical trial candidates include VAXinia (CF33 + hNIS), CHECKvacc (CF33 + hNIS + PD-L1), B-Vaxx and others.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellStrong SellStrong SellBuy
Technical IndicatorsStrong BuySellStrong SellStrong SellBuy
SummaryBuySellStrong SellStrong SellBuy
  • What will happen after virus
    0
    • Looking forward the AGM today. Time to sky rocket!
      0
      • Just just need to get through the CR fluff.
        0
        • this is about to explode, just waiting on some interim results now and if the results are good
          0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.